PLD for use in combination in the treatment of coronavirus
AssigneePharma Mar, S.A.
InventorsNuria Izquierdo-Useros, Júlia Vergara-Alert, Pablo Avilés Marín, Alejandro Losada González, José María Fernández Sousa-Faro, Salvador Fudio Muñoz
Life of this patent
Estimating the term…
Abstract
The use of PLD with one or more further CoV antiviral agent(s) in the treatment of coronavirus (CoV) infection.
Claims26
A method of treating coronavirus (CoV) infection comprising administering to a patient in need thereof PLD or a pharmaceutically acceptable salt or stereoisomer thereof, wherein PLD or a pharmaceutically acceptable salt or stereoisomer thereof is used in combination with remdesivir.
A combination of PLD or a pharmaceutically acceptable salt or stereoisomer thereof, and remdesivir.
A kit comprising a combination of PLD or a pharmaceutically acceptable salt or stereoisomer thereof, and remdesivir;
- said kit optionally further comprising instructions for the use of combination(s) according to the present invention for use in the treatment of coronavirus (CoV) infection.
A method of reducing viral load in a cell or reducing the infection efficiency of a virus in a cell or reducing viral propagation in a cell or reducing viral replication in a cell, said method comprising contacting a cell with PLD or a pharmaceutically acceptable salt or stereoisomer thereof in combination with remdesivir.
Dependencies are inferred from the claim text.